Anaïs Olivier is an expert in Nuclear medicine at Centre Oscar Lambret (France). Anaïs Olivier has authored 14 publications, the most recent in 2026. SLR score: 34 (community average: 125). How the SLR is computed.

LeadR Profile

Anaïs Olivier Centre Oscar Lambret France
34 ScienceLeadR Reputation 34
Network Map

Nuclear medicine

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 14

Citations

Citations: 64 1st author: 1 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prognostic Value of a Composite Score Incorporating Baseline [ 18F]FDG PET/CT and [ 68Ga]Ga-PSMA-11 PET/CT When Screening for [ 177Lu]Lu-PSMA Treatment Eligibility (PROFILE Study).
PMID 42463288 — hemoglobins, neoplasms, prostate, positron emission tomography computed tomography, fluorodeoxyglucose f18, prostatic neoplasms, castration, therapeutics, prognosis
J Nucl Med20260
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
PMID 40015915 — radiotherapy, cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, chemoradiotherapy, nuclear medicine
J Nucl Med20250
Therapeutic impact of F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.
PMID 38837087 — triple negative breast neoplasms, breast neoplasms, neoplasms, positron emission tomography computed tomography, breast, therapeutics
Breast Cancer Res Treat20243
Asymmetric kinetics of volume and function of the remnant liver after major hepatectomy as a key for postoperative outcome - A case-matched study.
PMID 31669198 — radionuclide imaging, liver diseases, hepatectomy
HPB (Oxford)201911
Évaluation de l’impact pronostique de la TEP au 18-FDG dans le bilan initial des sarcomes d’Ewing osseux en pédiatrie
OpenAlex W3191321876 — sarcoma, pediatrics
MED NUCL20210

LeadR Networks

Main global connection map